A phase 2 open-label clinical study using intravenous Paxceed [paclitaxel] to treat patients with rheumatoid arthritis
Phase of Trial: Phase II
Latest Information Update: 28 Jul 2008
At a glance
- Drugs Paclitaxel (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 28 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 27 Oct 2005 New trial record.